Public Company News

Actinogen announces first patient treated in depression and cognitive impairment Phase 2 clinical trial

Approximately 5% of Americans suffer from Major Depressive Disorder (MDD),[1]  which is commonly associated with "foggy thinking" but a new clinical trial raises hope that once-a-day oral drug Xanamem® may assist where treatment by anti-depressant medication alone is inadequate SYDNEY, Dec. 14, 2...

2022-12-14 21:52 2759

E-Home Household Services Holdings Limited's subsidiary Zhong Run Launches Cloud Pharmacy Service to Address New Situation of Epidemic Prevention and Control

FUZHOU, China, Dec. 14, 2022 /PRNewswire/ -- E-Home Household Service Holdings Limited (Nasdaq: EJH) (the "Company" or "E-Home"), a provider of integrated household services inChina, today announced that the Company's subsidiary Zhongrun (Fujian) Pharmaceutical Co., Ltd. ("Zhongrun") plan to expa...

2022-12-14 21:30 3241

Farmmi Announces Latest Sale in the Middle East

LISHUI, China, Dec. 14, 2022 /PRNewswire/ -- Farmmi, Inc. ("Farmmi" or the "Company") (NASDAQ: FAMI), an agricultural products supplier inChina, today announced its latest high volume order shipping to theMiddle East. The repeat multi-product order for the Company's dried Shiitake mushrooms and b...

2022-12-14 21:00 2695

Quhuo Ramps up Staff Support

BEIJING, Dec. 14, 2022 /PRNewswire/ -- Quhuo Limited (NASDAQ: QH) ("Quhuo" or "the Company"), a leading gig economy platform focusing on local community-centered services in China, has ramped up its efforts to offer more physical and mental support during the winter, as the Company continues to ...

2022-12-14 19:00 3657

Pacifico Acquisition Corp. Announces Intention to Extend Period to Consummate Business Combination

NEW YORK, Dec. 14, 2022 /PRNewswire/ -- Pacifico Acquisition Corp. (NASDAQ: PAFOU; the "Company") announced today that its sponsor, Pacifico Capital LLC (the "Sponsor"), notified the Company that if the Company does not complete a business combination byDecember 16, 2022, the Sponsor intends to d...

2022-12-14 16:37 3123

Tuniu Has Regained Compliance with Nasdaq's Minimum Bid Price Requirement

NANJING, China, Dec. 14, 2022 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company inChina, today announced that it has received a notification letter (the "Compliance Notice") from the Listing Qualifications Department of the Nasdaq...

2022-12-14 16:00 3479

SK Biopharmaceuticals Unveils Vision for Digital Healthcare

SK Biopharmaceuticals aims to become a 'total healthcare solution provider' as it strengthens its digital business ecosystem under 'Project ZeroTM' SK Biopharmaceuticals plans to showcase wearable devices, including CES® 2023 Innovation Awards winners'Zero GlassesTM,' 'Zero WiredTM' at the world'...

2022-12-14 10:00 2844

Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022

GERMANTOWN, Md. and HONG KONG, Dec. 13, 2022 /PRNewswire/ -- Sirnaomics Ltd. ( the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in the discovery and development of advanced therapeutics centered around the messenger RNA ("mRNA"), announced today that its Ex...

2022-12-14 01:40 2752

WiMi Announces Its Subsidiary MicroAlgo (MLGO.US) To Be Listed On NASDAQ Valued At $400 Million

BEIJING, Dec. 13, 2022 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that VIYI Algorithm Inc., ("VIYI Algo" ), a company controlled by WiMi, has completed a merger with Ven...

2022-12-13 21:30 3532

"Bleach: Brave Souls" Bankai Live 2022 Wrap-Up Super Thanks Special Airs Monday, December 26th

TOKYO, Dec. 13, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its hit 3D action gameBleach: Brave Souls, currently available on smartphones, PC, and PlayStation 4, will host the "Bleach: Brave Souls" Bankai Live 2022 Wrap-Up Super Thanks Special live broadcast on...

2022-12-13 20:30 2841

ChipMOS to Present at Credit Suisse 2023 Greater China Technology and Internet Conference

HSINCHU, Dec. 13, 2022 /PRNewswire-FirstCall/ -- ChipMOS TECHNOLOGIES INC. ("ChipMOS" or the "Company") (Taiwan Stock Exchange:8150 and NASDAQ: IMOS), an industry leading provider of outsourced semiconductor assembly and test services ("OSAT"),...

2022-12-13 19:00 2662

Live from ASH 2022 | Ascentage Pharma Presents Latest Data of APG-2575, Including Encouraging Results of the Combination with BTKi in Patients with R/R CLL/SLL

SUZHOU, China and ROCKVILLE, Md. , Dec. 13, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that it has released preliminary results from a ...

2022-12-13 17:39 2654

Venus Acquisition Corporation Announces Closing of Business Combination; MicroAlgo Inc. to trade on Nasdaq under the Symbol "MLGO".

NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Venus Acquisition Corporation (the "Company" or "Venus") (NASDAQ: VENA) today announced that, onDecember 9, 2022, the Company closed the previously announced business combination (the "Business Combination") with VIYI Algorithm Inc. (the "VIYI") pursuant...

2022-12-13 00:25 4082

TD Holdings, Inc. Awarded Top 100 China Industrial Internet Enterprise of 2022

SHENZHEN, China, Dec. 12, 2022 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider in China, today announced that its online to offline e-commerce commodities trading platform, tongdow.com, was awarded Top 100 China Industrial Internet Enterpris...

2022-12-12 22:00 4192

Pop Culture Group's Joint Venture to Receive Growth Investment from Nest Investment Management Co., Ltd.

XIAMEN, China, Dec. 12, 2022 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company's joint venture, Shenzhen Jam Box Technology Co., Ltd ("JBT"), entered into an equity investme...

2022-12-12 22:00 3948

CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatat the 2022 American Society of Hematology (the "ASH") Annual Mee...

2022-12-12 21:50 3048

Yum China Achieves Highest Score in its Industry for the Third Consecutive Year on the Dow Jones Sustainability Index

Green power purchase program launched with two pilot restaurants SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) today announced that the Company was ranked the best in the 88 companies assessed in the Restaurant & Leisur...

2022-12-12 21:41 3839

Tantech Participated in Setting International Standards for Bamboo-based Activated Carbon

LISHUI, China, Dec. 12, 2022 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that its subsidiary, Zhejiang Tantech Bamboo Charcoal Co., Ltd., had received a certificate from the Bamboo and Rattan Technical Committee of the International Organizatio...

2022-12-12 21:30 3163

PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)

DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company has entered into a clinical collaboration agreement with MSD (Merck & Co...

2022-12-12 21:00 2996

Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that Hexvix®, a drug used for bladder c...

2022-12-12 20:59 2311
1 ... 525526527528529530531 ... 763

Week's Top Stories